These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34992336)

  • 1. The Prognostic Significance of Proteasome 26S Subunit, Non-ATPase (PSMD) Genes for Bladder Urothelial Carcinoma Patients.
    Salah Fararjeh A; Al-Khader A; Al-Saleem M; Abu Qauod R
    Cancer Inform; 2021; 20():11769351211067692. PubMed ID: 34992336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
    Li X; Li X; Hu Y; Liu O; Wang Y; Li S; Yang Q; Lin B
    BMC Cancer; 2023 Jun; 23(1):573. PubMed ID: 37349676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients.
    Xuan DTM; Wu CC; Kao TJ; Ta HDK; Anuraga G; Andriani V; Athoillah M; Chiao CC; Wu YF; Lee KH; Wang CY; Chuang JY
    Aging (Albany NY); 2021 Nov; 13(22):24882-24913. PubMed ID: 34839279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma.
    Li Y; Liu X; Zhao F; Zhao Z; Li X; Wang J; Huang B; Chen A
    CNS Neurosci Ther; 2024 Feb; 30(2):e14366. PubMed ID: 37485655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.
    Wu Y; Peng Y; Guan B; He A; Yang K; He S; Gong Y; Li X; Zhou L
    Oncol Lett; 2021 Feb; 21(2):95. PubMed ID: 33376528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer.
    Zhang P; Yang Q
    Front Genet; 2021; 12():682856. PubMed ID: 34149818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
    Ni W; Yi L; Dong X; Cao M; Zheng J; Wei Q; Yuan C
    Sci Rep; 2023 Feb; 13(1):2051. PubMed ID: 36739300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of
    Lin B; Zhang T; Ye X; Yang H
    Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of RAC3 in bladder cancer predicts adverse clinical outcome and increased tumor immune response.
    Ou-Yang S; Liu JH; Wang QZ
    Int J Clin Exp Pathol; 2020; 13(12):2937-2949. PubMed ID: 33425095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
    Chen R; Jiang M; Hu B; Fu B; Sun T
    Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma.
    Li X; Huang J; Chen J; Zhan Y; Zhang R; Lu E; Li C; Zhang Y; Wang Y; Li Y; Zheng J; Geng W
    Front Oncol; 2021; 11():726486. PubMed ID: 34966666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.
    Luan JC; Zeng TY; Zhang QJ; Xia DR; Cong R; Yao LY; Song LB; Zhou X; Zhou X; Chen X; Xia JD; Song NH
    Cancer Cell Int; 2021 Aug; 21(1):414. PubMed ID: 34362387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
    Liu M; Chen S; Zhang A; Zheng Q; Fu J
    J Inflamm Res; 2021; 14():4629-4641. PubMed ID: 34552345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of SNCA and its methylation in bladder cancer.
    Wu Z; Xia C; Zhang C; Yang D; Ma K
    BMC Cancer; 2022 Mar; 22(1):330. PubMed ID: 35346107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices.
    Pan S; Zhan Y; Chen X; Wu B; Liu B
    Front Oncol; 2019; 9():613. PubMed ID: 31334127
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma.
    Zhao H; Lu G
    Front Genet; 2022; 13():905581. PubMed ID: 35754829
    [No Abstract]   [Full Text] [Related]  

  • 18. Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses.
    Sun S; Wang Y; Wang J; Bi J
    J Transl Med; 2021 Sep; 19(1):409. PubMed ID: 34579753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value and Molecular Mechanisms of Proteasome 26S Subunit, Non-ATPase Family Genes for Pancreatic Ductal Adenocarcinoma Patients after Pancreaticoduodenectomy.
    Zhou C; Li H; Han X; Pang H; Wu M; Tang Y; Luo X
    J Invest Surg; 2022 Feb; 35(2):330-346. PubMed ID: 33525943
    [No Abstract]   [Full Text] [Related]  

  • 20. KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma.
    Zhao K; Gao M; Lin M
    Dis Markers; 2022; 2022():3373851. PubMed ID: 36193495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.